Skip to main content

Revamped Overdose Prevention Strategy Enhances Harm Reduction Efforts Across Oklahoma

Friday, September 13, 2024

Today, ODMHSAS is announcing a significant update to our approach to distributing naloxone and fentanyl test strips. Effective immediately, we will be withdrawing our vending machines from the field and transitioning to a more efficient and strategic distribution plan.

This decision follows a comprehensive evaluation of the vending machine program’s performance. While the initiative succeeded in raising awareness and improving access to critical overdose prevention resources, it has become evident that the vending machines did not achieve the expected outcomes. Our review has shown that the program was less cost-effective than anticipated and did not deliver the data-supported results ODMHSAS had wanted to achieve.

“An initiative that was originally launched as a pilot program under previous leadership has been thoroughly evaluated over time,” said Commissioner Allie Friesen. “After reviewing the financial implications, data, and overall outcomes, it has become evident that the program has not proven to be cost-effective, nor has it consistently delivered the positive results we had hoped for. As a result, we are re-evaluating our approach to ensure that future initiatives are aligned with our goals for both financial sustainability and improved outcomes for those we serve.”

The Harm Reduction vending machine campaign aimed to address the opioid crisis, which is now the leading cause of death for individuals in the U.S. under 50. The campaign focused on reducing accidental overdoses in Oklahoma through education, awareness, and providing resources such as naloxone and fentanyl test strips. Naloxone, an opioid antagonist, reverses and blocks the effects of opioids, while fentanyl test strips detect the presence of fentanyl in various substances.  

Friesen reassures that both resources will continue to be available statewide to Oklahomans free of charge and more money can be invested in agency initiatives and treatment.

In 2023 alone, we shipped 148,886 two-dose lifesaving naloxone kits and 108,306 fentanyl test strips through the mail-out program, averaging around 1,200 shipments every month. However, maintaining vending machines across our network of over 400 community partners, including schools, businesses, advocacy groups, and law enforcement, posed significant operational challenges. In addition, we also provide units for all Certified Community Behavioral Health Centers, hospitals, Department of Corrections, and Office of Juvenile Affairs. Issues such as stock shortages, machine malfunctions, and logistical difficulties strained our partners and impacted our collective mission.

"Overdose education and naloxone distribution is a core strategy to reduce opioid overdose deaths in Oklahoma," said Andrea Hamor Edmondson, Senior Prevention Program Manager. "Since 2012, the Prevention Division of the ODMHSAS has been working with community partners including law enforcement, community-based businesses and nonprofits, schools, the medical community and other state agencies to ensure that naloxone is available wherever overdose happens."

Our revised strategy involves replacing the vending machines with marketing posters featuring QR codes. These codes will direct individuals to access points and provide information on receiving products by mail. Through existing community partnerships, we will continue to provide overdose education and naloxone distribution services across the state and equip first responders and members of the public. 

"By adopting this revised strategy, we aim to provide a more effective and efficient experience for everyone involved," Hamor Edmondson added. "This transition will allow us to conserve resources and reinvest them into our agency’s strategic initiatives, ensuring we continue to deliver high-quality services to those in need."

Pickups of the vending machines will start immediately and are expected to be completed by the end of the month. We are aware that some partners have expressed interest in acquiring the machines. Although current statutory requirements prevent direct transfers of ownership, we are exploring potential future options, including a possible auction, and will update interested parties as more information becomes available. 

For immediate needs of naloxone, fentanyl test strips, or other prevention materials, please contact the Overdose Prevention team at overdose.prevention@odmhsas.org or visit okimready.org/overdose to place an order.

Kelsey Davis

Sr. Director of Communications
405-905-8684

Back to Top